{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:19:18Z","timestamp":1740460758493,"version":"3.37.3"},"reference-count":11,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2024,7,30]]},"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1183\/13993003.01247-2024","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T09:45:39Z","timestamp":1727343939000},"page":"2401247","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply: Reversal of structural abnormalities with elexacaftor\/tezacaftor\/ivacaftor in adults with cystic fibrosis: the earlier you start, the better the outcome will be!"],"prefix":"10.1183","volume":"64","author":[{"given":"Guillaume","family":"Chassagnon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-9828","authenticated-orcid":false,"given":"Pierre-R\u00e9gis","family":"Burgel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"2024102017362547000_64.3.2401247.1","doi-asserted-by":"crossref","first-page":"e01172","DOI":"10.1002\/rcr2.1172","article-title":"Cystic fibrosis modulator therapy can reverse cystic bronchiectasis","volume":"11","author":"Middleton","year":"2023","journal-title":"Respirol Case Rep"},{"key":"2024102017362547000_64.3.2401247.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01794-2023"},{"key":"2024102017362547000_64.3.2401247.3","doi-asserted-by":"crossref","first-page":"E249","DOI":"10.1148\/radiol.2021210339","article-title":"Post-COVID-19 vanishing paraseptal emphysema","volume":"299","author":"Cabanne","year":"2021","journal-title":"Radiology"},{"key":"2024102017362547000_64.3.2401247.4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01918-2015"},{"key":"2024102017362547000_64.3.2401247.5","doi-asserted-by":"crossref","first-page":"2101344","DOI":"10.1183\/13993003.01344-2021","article-title":"Using chest CT scan and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis","volume":"59","author":"Campredon","year":"2021","journal-title":"Eur Respir J"},{"key":"2024102017362547000_64.3.2401247.6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jcf.2022.03.011","article-title":"Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor\/tezacaftor\/ivacaftor therapy in adults with cystic fibrosis","volume":"21","author":"Wucherpfennig","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2024102017362547000_64.3.2401247.7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.202201-0219OC","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on lung clearance index and magnetic resonance imaging in patients with cystic fibrosis and one or two F508del alleles","volume":"206","author":"Graeber","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102017362547000_64.3.2401247.8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1164\/rccm.202308-1317OC","article-title":"Improvement in lung clearance index and chest computed tomography scores with elexacaftor\/tezacaftor\/ivacaftor treatment in people with cystic fibrosis aged 12 years and older \u2013 The RECOVER trial","volume":"208","author":"McNally","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102017362547000_64.3.2401247.9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1164\/rccm.202402-0411OC","article-title":"Radiographic outcomes in pediatric bronchiectasis and factors associated with reversibility","volume":"210","author":"Mills","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102017362547000_64.3.2401247.10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1164\/rccm.202404-0764ED","article-title":"Reversal of bronchiectasis in children: early intervention may stop the vicious circle!","volume":"210","author":"Burgel","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102017362547000_64.3.2401247.11","first-page":"2101344","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles","volume":"59","author":"Stahl","year":"2024","journal-title":"Eur Respir J"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01247-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:23:01Z","timestamp":1740381781000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01247-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":11,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9,26]]},"published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1183\/13993003.01247-2024"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01247-2024","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"type":"print","value":"0903-1936"},{"type":"electronic","value":"1399-3003"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}